Global Nuclear Pharmacy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market by Type
  • 1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
  • 1.2.2 Diagnostic Products
  • 1.2.3 Therapeutic Products
• 1.3 Market by Application
  • 1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Pharmaceutical
  • 1.3.3 Hospital
  • 1.3.4 Laboratory
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Nuclear Pharmacy Market Perspective (2020-2031)
• 2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
• 2.3 Global Nuclear Pharmacy Revenue Market Share by Region (2020-2025)
• 2.4 Global Nuclear Pharmacy Revenue Forecast by Region (2026-2031)
• 2.5 Major Region and Emerging Market Analysis
  • 2.5.1 North America Nuclear Pharmacy Market Size and Prospective (2020-2031)
  • 2.5.2 Europe Nuclear Pharmacy Market Size and Prospective (2020-2031)
  • 2.5.3 Asia-Pacific Nuclear Pharmacy Market Size and Prospective (2020-2031)
  • 2.5.4 Latin America Nuclear Pharmacy Market Size and Prospective (2020-2031)
  • 2.5.5 Middle East & Africa Nuclear Pharmacy Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

• 3.1 Global Nuclear Pharmacy Historic Market Size by Type (2020-2025)
• 3.2 Global Nuclear Pharmacy Forecasted Market Size by Type (2026-2031)
• 3.3 Different Types Nuclear Pharmacy Representative Players

4 Breakdown Data by Application

• 4.1 Global Nuclear Pharmacy Historic Market Size by Application (2020-2025)
• 4.2 Global Nuclear Pharmacy Forecasted Market Size by Application (2026-2031)
• 4.3 New Sources of Growth in Nuclear Pharmacy Application

5 Competition Landscape by Players

• 5.1 Global Top Players by Revenue
  • 5.1.1 Global Top Nuclear Pharmacy Players by Revenue (2020-2025)
  • 5.1.2 Global Nuclear Pharmacy Revenue Market Share by Players (2020-2025)
• 5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 5.3 Players Covered: Ranking by Nuclear Pharmacy Revenue
• 5.4 Global Nuclear Pharmacy Market Concentration Analysis
  • 5.4.1 Global Nuclear Pharmacy Market Concentration Ratio (CR5 and HHI)
  • 5.4.2 Global Top 10 and Top 5 Companies by Nuclear Pharmacy Revenue in 2024
• 5.5 Global Key Players of Nuclear Pharmacy Head office and Area Served
• 5.6 Global Key Players of Nuclear Pharmacy, Product and Application
• 5.7 Global Key Players of Nuclear Pharmacy, Date of Enter into This Industry
• 5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

• 6.1 North America Market: Players, Segments and Downstream
  • 6.1.1 North America Nuclear Pharmacy Revenue by Company (2020-2025)
  • 6.1.2 North America Market Size by Type
    • 6.1.2.1 North America Nuclear Pharmacy Market Size by Type (2020-2025)
    • 6.1.2.2 North America Nuclear Pharmacy Market Share by Type (2020-2025)
  • 6.1.3 North America Market Size by Application
    • 6.1.3.1 North America Nuclear Pharmacy Market Size by Application (2020-2025)
    • 6.1.3.2 North America Nuclear Pharmacy Market Share by Application (2020-2025)
  • 6.1.4 North America Market Trend and Opportunities
• 6.2 Europe Market: Players, Segments and Downstream
  • 6.2.1 Europe Nuclear Pharmacy Revenue by Company (2020-2025)
  • 6.2.2 Europe Market Size by Type
    • 6.2.2.1 Europe Nuclear Pharmacy Market Size by Type (2020-2025)
    • 6.2.2.2 Europe Nuclear Pharmacy Market Share by Type (2020-2025)
  • 6.2.3 Europe Market Size by Application
    • 6.2.3.1 Europe Nuclear Pharmacy Market Size by Application (2020-2025)
    • 6.2.3.2 Europe Nuclear Pharmacy Market Share by Application (2020-2025)
  • 6.2.4 Europe Market Trend and Opportunities
• 6.3 Asia-Pacific Market: Players, Segments and Downstream
  • 6.3.1 Asia-Pacific Nuclear Pharmacy Revenue by Company (2020-2025)
  • 6.3.2 Asia-Pacific Market Size by Type
    • 6.3.2.1 Asia-Pacific Nuclear Pharmacy Market Size by Type (2020-2025)
    • 6.3.2.2 Asia-Pacific Nuclear Pharmacy Market Share by Type (2020-2025)
  • 6.3.3 Asia-Pacific Market Size by Application
    • 6.3.3.1 Asia-Pacific Nuclear Pharmacy Market Size by Application (2020-2025)
    • 6.3.3.2 Asia-Pacific Nuclear Pharmacy Market Share by Application (2020-2025)
  • 6.3.4 Asia-Pacific Market Trend and Opportunities
• 6.4 Latin America Market: Players, Segments and Downstream
  • 6.4.1 Latin America Nuclear Pharmacy Revenue by Company (2020-2025)
  • 6.4.2 Latin America Market Size by Type
    • 6.4.2.1 Latin America Nuclear Pharmacy Market Size by Type (2020-2025)
    • 6.4.2.2 Latin America Nuclear Pharmacy Market Share by Type (2020-2025)
  • 6.4.3 Latin America Market Size by Application
    • 6.4.3.1 Latin America Nuclear Pharmacy Market Size by Application (2020-2025)
    • 6.4.3.2 Latin America Nuclear Pharmacy Market Share by Application (2020-2025)
  • 6.4.4 Latin America Market Trend and Opportunities
• 6.5 Middle East & Africa Market: Players, Segments and Downstream
  • 6.5.1 Middle East & Africa Nuclear Pharmacy Revenue by Company (2020-2025)
  • 6.5.2 Middle East & Africa Market Size by Type
    • 6.5.2.1 Middle East & Africa Nuclear Pharmacy Market Size by Type (2020-2025)
    • 6.5.2.2 Middle East & Africa Nuclear Pharmacy Market Share by Type (2020-2025)
  • 6.5.3 Middle East & Africa Market Size by Application
    • 6.5.3.1 Middle East & Africa Nuclear Pharmacy Market Size by Application (2020-2025)
    • 6.5.3.2 Middle East & Africa Nuclear Pharmacy Market Share by Application (2020-2025)
  • 6.5.4 Middle East & Africa Market Trend and Opportunities

7 Key Players Profiles

• 7.1 Bayer
  • 7.1.1 Bayer Company Details
  • 7.1.2 Bayer Business Overview
  • 7.1.3 Bayer Nuclear Pharmacy Introduction
  • 7.1.4 Bayer Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.1.5 Bayer Recent Development
• 7.2 Curium Pharma
  • 7.2.1 Curium Pharma Company Details
  • 7.2.2 Curium Pharma Business Overview
  • 7.2.3 Curium Pharma Nuclear Pharmacy Introduction
  • 7.2.4 Curium Pharma Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.2.5 Curium Pharma Recent Development
• 7.3 Jubilant Pharmova
  • 7.3.1 Jubilant Pharmova Company Details
  • 7.3.2 Jubilant Pharmova Business Overview
  • 7.3.3 Jubilant Pharmova Nuclear Pharmacy Introduction
  • 7.3.4 Jubilant Pharmova Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.3.5 Jubilant Pharmova Recent Development
• 7.4 GE Healthcare
  • 7.4.1 GE Healthcare Company Details
  • 7.4.2 GE Healthcare Business Overview
  • 7.4.3 GE Healthcare Nuclear Pharmacy Introduction
  • 7.4.4 GE Healthcare Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.4.5 GE Healthcare Recent Development
• 7.5 Cardinal Health
  • 7.5.1 Cardinal Health Company Details
  • 7.5.2 Cardinal Health Business Overview
  • 7.5.3 Cardinal Health Nuclear Pharmacy Introduction
  • 7.5.4 Cardinal Health Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.5.5 Cardinal Health Recent Development
• 7.6 Eli Lilly
  • 7.6.1 Eli Lilly Company Details
  • 7.6.2 Eli Lilly Business Overview
  • 7.6.3 Eli Lilly Nuclear Pharmacy Introduction
  • 7.6.4 Eli Lilly Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.6.5 Eli Lilly Recent Development
• 7.7 Bracco Imaging
  • 7.7.1 Bracco Imaging Company Details
  • 7.7.2 Bracco Imaging Business Overview
  • 7.7.3 Bracco Imaging Nuclear Pharmacy Introduction
  • 7.7.4 Bracco Imaging Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.7.5 Bracco Imaging Recent Development
• 7.8 China Isotope & Radiation
  • 7.8.1 China Isotope & Radiation Company Details
  • 7.8.2 China Isotope & Radiation Business Overview
  • 7.8.3 China Isotope & Radiation Nuclear Pharmacy Introduction
  • 7.8.4 China Isotope & Radiation Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.8.5 China Isotope & Radiation Recent Development
• 7.9 Novartis
  • 7.9.1 Novartis Company Details
  • 7.9.2 Novartis Business Overview
  • 7.9.3 Novartis Nuclear Pharmacy Introduction
  • 7.9.4 Novartis Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.9.5 Novartis Recent Development
• 7.10 Siemens
  • 7.10.1 Siemens Company Details
  • 7.10.2 Siemens Business Overview
  • 7.10.3 Siemens Nuclear Pharmacy Introduction
  • 7.10.4 Siemens Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.10.5 Siemens Recent Development
• 7.11 Lantheus Medical Imaging
  • 7.11.1 Lantheus Medical Imaging Company Details
  • 7.11.2 Lantheus Medical Imaging Business Overview
  • 7.11.3 Lantheus Medical Imaging Nuclear Pharmacy Introduction
  • 7.11.4 Lantheus Medical Imaging Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.11.5 Lantheus Medical Imaging Recent Development
• 7.12 Aurobindo Pharma
  • 7.12.1 Aurobindo Pharma Company Details
  • 7.12.2 Aurobindo Pharma Business Overview
  • 7.12.3 Aurobindo Pharma Nuclear Pharmacy Introduction
  • 7.12.4 Aurobindo Pharma Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.12.5 Aurobindo Pharma Recent Development
• 7.13 ANSTO
  • 7.13.1 ANSTO Company Details
  • 7.13.2 ANSTO Business Overview
  • 7.13.3 ANSTO Nuclear Pharmacy Introduction
  • 7.13.4 ANSTO Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.13.5 ANSTO Recent Development
• 7.14 Polatom
  • 7.14.1 Polatom Company Details
  • 7.14.2 Polatom Business Overview
  • 7.14.3 Polatom Nuclear Pharmacy Introduction
  • 7.14.4 Polatom Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.14.5 Polatom Recent Development
• 7.15 NTP Radioisotopes
  • 7.15.1 NTP Radioisotopes Company Details
  • 7.15.2 NTP Radioisotopes Business Overview
  • 7.15.3 NTP Radioisotopes Nuclear Pharmacy Introduction
  • 7.15.4 NTP Radioisotopes Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.15.5 NTP Radioisotopes Recent Development
• 7.16 Yantai Dongcheng Pharmaceutical
  • 7.16.1 Yantai Dongcheng Pharmaceutical Company Details
  • 7.16.2 Yantai Dongcheng Pharmaceutical Business Overview
  • 7.16.3 Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Introduction
  • 7.16.4 Yantai Dongcheng Pharmaceutical Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.16.5 Yantai Dongcheng Pharmaceutical Recent Development
• 7.17 Saide Biotechnology
  • 7.17.1 Saide Biotechnology Company Details
  • 7.17.2 Saide Biotechnology Business Overview
  • 7.17.3 Saide Biotechnology Nuclear Pharmacy Introduction
  • 7.17.4 Saide Biotechnology Revenue in Nuclear Pharmacy Business (2020-2025)
  • 7.17.5 Saide Biotechnology Recent Development

8 Nuclear Pharmacy Market Dynamics

• 8.1 Nuclear Pharmacy Industry Trends
• 8.2 Nuclear Pharmacy Market Drivers
• 8.3 Nuclear Pharmacy Market Challenges
• 8.4 Nuclear Pharmacy Market Restraints

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer

List of Tables

• Table 1. Global Nuclear Pharmacy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
• Table 2. Global Nuclear Pharmacy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
• Table 3. Global Market Nuclear Pharmacy Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
• Table 4. Global Nuclear Pharmacy Revenue (US$ Million) Market Share by Region (2020-2025)
• Table 5. Global Nuclear Pharmacy Revenue Share by Region (2020-2025)
• Table 6. Global Nuclear Pharmacy Revenue (US$ Million) Forecast by Region (2026-2031)
• Table 7. Global Nuclear Pharmacy Revenue Share Forecast by Region (2026-2031)
• Table 8. Global Nuclear Pharmacy Market Size by Type (2020-2025) & (US$ Million)
• Table 9. Global Nuclear Pharmacy Revenue Market Share by Type (2020-2025)
• Table 10. Global Nuclear Pharmacy Forecasted Market Size by Type (2026-2031) & (US$ Million)
• Table 11. Global Nuclear Pharmacy Revenue Market Share by Type (2026-2031)
• Table 12. Representative Players of Each Type
• Table 13. Global Nuclear Pharmacy Market Size by Application (2020-2025) & (US$ Million)
• Table 14. Global Nuclear Pharmacy Revenue Market Share by Application (2020-2025)
• Table 15. Global Nuclear Pharmacy Forecasted Market Size by Application (2026-2031) & (US$ Million)
• Table 16. Global Nuclear Pharmacy Revenue Market Share by Application (2026-2031)
• Table 17. New Sources of Growth in Nuclear Pharmacy Application
• Table 18. Global Nuclear Pharmacy Revenue by Players (2020-2025) & (US$ Million)
• Table 19. Global Nuclear Pharmacy Market Share by Players (2020-2025)
• Table 20. Global Top Nuclear Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Pharmacy as of 2024)
• Table 21. Ranking of Global Top Nuclear Pharmacy Companies by Revenue (US$ Million) in 2024
• Table 22. Global 5 Largest Players Market Share by Nuclear Pharmacy Revenue (CR5 and HHI) & (2020-2025)
• Table 23. Global Key Players of Nuclear Pharmacy, Headquarters and Area Served
• Table 24. Global Key Players of Nuclear Pharmacy, Product and Application
• Table 25. Global Key Players of Nuclear Pharmacy, Date of Enter into This Industry
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. North America Nuclear Pharmacy Revenue by Company (2020-2025) & (US$ Million)
• Table 28. North America Nuclear Pharmacy Revenue Market Share by Company (2020-2025)
• Table 29. North America Nuclear Pharmacy Market Size by Type (2020-2025) & (US$ Million)
• Table 30. North America Nuclear Pharmacy Market Size by Application (2020-2025) & (US$ Million)
• Table 31. Europe Nuclear Pharmacy Revenue by Company (2020-2025) & (US$ Million)
• Table 32. Europe Nuclear Pharmacy Revenue Market Share by Company (2020-2025)
• Table 33. Europe Nuclear Pharmacy Market Size by Type (2020-2025) & (US$ Million)
• Table 34. Europe Nuclear Pharmacy Market Size by Application (2020-2025) & (US$ Million)
• Table 35. Asia-Pacific Nuclear Pharmacy Revenue by Company (2020-2025) & (US$ Million)
• Table 36. Asia-Pacific Nuclear Pharmacy Revenue Market Share by Company (2020-2025)
• Table 37. Asia-Pacific Nuclear Pharmacy Market Size by Type (2020-2025) & (US$ Million)
• Table 38. Asia-Pacific Nuclear Pharmacy Market Size by Application (2020-2025) & (US$ Million)
• Table 39. Latin America Nuclear Pharmacy Revenue by Company (2020-2025) & (US$ Million)
• Table 40. Latin America Nuclear Pharmacy Revenue Market Share by Company (2020-2025)
• Table 41. Latin America Nuclear Pharmacy Market Size by Type (2020-2025) & (US$ Million)
• Table 42. Latin America Nuclear Pharmacy Market Size by Application (2020-2025) & (US$ Million)
• Table 43. Middle East & Africa Nuclear Pharmacy Revenue by Company (2020-2025) & (US$ Million)
• Table 44. Middle East & Africa Nuclear Pharmacy Revenue Market Share by Company (2020-2025)
• Table 45. Middle East & Africa Nuclear Pharmacy Market Size by Type (2020-2025) & (US$ Million)
• Table 46. Middle East & Africa Nuclear Pharmacy Market Size by Application (2020-2025) & (US$ Million)
• Table 47. Bayer Company Details
• Table 48. Bayer Business Overview
• Table 49. Bayer Nuclear Pharmacy Product
• Table 50. Bayer Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 51. Bayer Recent Development
• Table 52. Curium Pharma Company Details
• Table 53. Curium Pharma Business Overview
• Table 54. Curium Pharma Nuclear Pharmacy Product
• Table 55. Curium Pharma Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 56. Curium Pharma Recent Development
• Table 57. Jubilant Pharmova Company Details
• Table 58. Jubilant Pharmova Business Overview
• Table 59. Jubilant Pharmova Nuclear Pharmacy Product
• Table 60. Jubilant Pharmova Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 61. Jubilant Pharmova Recent Development
• Table 62. GE Healthcare Company Details
• Table 63. GE Healthcare Business Overview
• Table 64. GE Healthcare Nuclear Pharmacy Product
• Table 65. GE Healthcare Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 66. GE Healthcare Recent Development
• Table 67. Cardinal Health Company Details
• Table 68. Cardinal Health Business Overview
• Table 69. Cardinal Health Nuclear Pharmacy Product
• Table 70. Cardinal Health Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 71. Cardinal Health Recent Development
• Table 72. Eli Lilly Company Details
• Table 73. Eli Lilly Business Overview
• Table 74. Eli Lilly Nuclear Pharmacy Product
• Table 75. Eli Lilly Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 76. Eli Lilly Recent Development
• Table 77. Bracco Imaging Company Details
• Table 78. Bracco Imaging Business Overview
• Table 79. Bracco Imaging Nuclear Pharmacy Product
• Table 80. Bracco Imaging Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 81. Bracco Imaging Recent Development
• Table 82. China Isotope & Radiation Company Details
• Table 83. China Isotope & Radiation Business Overview
• Table 84. China Isotope & Radiation Nuclear Pharmacy Product
• Table 85. China Isotope & Radiation Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 86. China Isotope & Radiation Recent Development
• Table 87. Novartis Company Details
• Table 88. Novartis Business Overview
• Table 89. Novartis Nuclear Pharmacy Product
• Table 90. Novartis Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 91. Novartis Recent Development
• Table 92. Siemens Company Details
• Table 93. Siemens Business Overview
• Table 94. Siemens Nuclear Pharmacy Product
• Table 95. Siemens Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 96. Siemens Recent Development
• Table 97. Lantheus Medical Imaging Company Details
• Table 98. Lantheus Medical Imaging Business Overview
• Table 99. Lantheus Medical Imaging Nuclear Pharmacy Product
• Table 100. Lantheus Medical Imaging Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 101. Lantheus Medical Imaging Recent Development
• Table 102. Aurobindo Pharma Company Details
• Table 103. Aurobindo Pharma Business Overview
• Table 104. Aurobindo Pharma Nuclear Pharmacy Product
• Table 105. Aurobindo Pharma Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 106. Aurobindo Pharma Recent Development
• Table 107. ANSTO Company Details
• Table 108. ANSTO Business Overview
• Table 109. ANSTO Nuclear Pharmacy Product
• Table 110. ANSTO Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 111. ANSTO Recent Development
• Table 112. Polatom Company Details
• Table 113. Polatom Business Overview
• Table 114. Polatom Nuclear Pharmacy Product
• Table 115. Polatom Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 116. Polatom Recent Development
• Table 117. NTP Radioisotopes Company Details
• Table 118. NTP Radioisotopes Business Overview
• Table 119. NTP Radioisotopes Nuclear Pharmacy Product
• Table 120. NTP Radioisotopes Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 121. NTP Radioisotopes Recent Development
• Table 122. Yantai Dongcheng Pharmaceutical Company Details
• Table 123. Yantai Dongcheng Pharmaceutical Business Overview
• Table 124. Yantai Dongcheng Pharmaceutical Nuclear Pharmacy Product
• Table 125. Yantai Dongcheng Pharmaceutical Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 126. Yantai Dongcheng Pharmaceutical Recent Development
• Table 127. Saide Biotechnology Company Details
• Table 128. Saide Biotechnology Business Overview
• Table 129. Saide Biotechnology Nuclear Pharmacy Product
• Table 130. Saide Biotechnology Revenue in Nuclear Pharmacy Business (2020-2025) & (US$ Million)
• Table 131. Saide Biotechnology Recent Development
• Table 132. Nuclear Pharmacy Market Trends
• Table 133. Nuclear Pharmacy Market Drivers
• Table 134. Nuclear Pharmacy Market Challenges
• Table 135. Nuclear Pharmacy Market Restraints
• Table 136. Research Programs/Design for This Report
• Table 137. Key Data Information from Secondary Sources
• Table 138. Key Data Information from Primary Sources

List of Figures

• Figure 1. Nuclear Pharmacy Product Picture
• Figure 2. Global Nuclear Pharmacy Market Share by Type: 2024 VS 2031
• Figure 3. Diagnostic Products Features
• Figure 4. Therapeutic Products Features
• Figure 5. Global Nuclear Pharmacy Market Share by Application: 2024 VS 2031
• Figure 6. Pharmaceutical
• Figure 7. Hospital
• Figure 8. Laboratory
• Figure 9. Nuclear Pharmacy Report Years Considered
• Figure 10. Global Nuclear Pharmacy Market Size (US$ Million), Year-over-Year: 2020-2031
• Figure 11. Global Nuclear Pharmacy Market Size, (US$ Million), 2020 VS 2024 VS 2031
• Figure 12. Global Nuclear Pharmacy Revenue Market Share by Region: 2020 VS 2024
• Figure 13. North America Nuclear Pharmacy Revenue (US$ Million) Growth Rate (2020-2031)
• Figure 14. Europe Nuclear Pharmacy Revenue (US$ Million) Growth Rate (2020-2031)
• Figure 15. Asia-Pacific Nuclear Pharmacy Revenue (US$ Million) Growth Rate (2020-2031)
• Figure 16. Latin America Nuclear Pharmacy Revenue (US$ Million) Growth Rate (2020-2031)
• Figure 17. Middle East & Africa Nuclear Pharmacy Revenue (US$ Million) Growth Rate (2020-2031)
• Figure 18. Global Nuclear Pharmacy Market Share by Players in 2024
• Figure 19. Global Top Nuclear Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Pharmacy as of 2024)
• Figure 20. The Top 10 and 5 Players Market Share by Nuclear Pharmacy Revenue in 2024
• Figure 21. North America Nuclear Pharmacy Market Share by Type (2020-2025)
• Figure 22. North America Nuclear Pharmacy Market Share by Application (2020-2025)
• Figure 23. Europe Nuclear Pharmacy Market Share by Type (2020-2025)
• Figure 24. Europe Nuclear Pharmacy Market Share by Application (2020-2025)
• Figure 25. Asia-Pacific Nuclear Pharmacy Market Share by Type (2020-2025)
• Figure 26. Asia-Pacific Nuclear Pharmacy Market Share by Application (2020-2025)
• Figure 27. Latin America Nuclear Pharmacy Market Share by Type (2020-2025)
• Figure 28. Latin America Nuclear Pharmacy Market Share by Application (2020-2025)
• Figure 29. Middle East & Africa Nuclear Pharmacy Market Share by Type (2020-2025)
• Figure 30. Middle East & Africa Nuclear Pharmacy Market Share by Application (2020-2025)
• Figure 31. Bayer Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 32. Curium Pharma Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 33. Jubilant Pharmova Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 34. GE Healthcare Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 35. Cardinal Health Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 36. Eli Lilly Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 37. Bracco Imaging Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 38. China Isotope & Radiation Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 39. Novartis Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 40. Siemens Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 41. Lantheus Medical Imaging Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 42. Aurobindo Pharma Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 43. ANSTO Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 44. Polatom Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 45. NTP Radioisotopes Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 46. Yantai Dongcheng Pharmaceutical Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 47. Saide Biotechnology Revenue Growth Rate in Nuclear Pharmacy Business (2020-2025)
• Figure 48. Bottom-up and Top-down Approaches for This Report
• Figure 49. Data Triangulation
• Figure 50. Key Executives Interviewed